AI designs new antibodies that pass blinded laboratory tests
Researchers affiliated with UTHealth Houston, competing under the team name Novamab AI, placed among the top five teams in the international AIntibody Challenge, a blinded, prospective benchmark published in Nature Biotechnology.
Researchers affiliated with UTHealth Houston, competing under the team name Novamab AI, placed among the top five teams in the international AIntibody Challenge, a blinded, prospective benchmark published in Nature Biotechnology. This story matters for Science & Discovery readers tracking engineering. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. EngineeringNews curates and briefs the science & discovery stories that matter. Our editorial policy →